Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China-Reference-Cited by-同舟云学术

Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China

Published:2024-05-28 Issue:8 Volume:103 Page:3061-3069
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Wang Wei,Zhang Wei^ORCID,Su Li-ping,Liu Li-hong,Gao Yu-huan,Wang Quan-shun,Su Hang,Song Yu-qin,Zhang Hui-lai,Shen Jing,Jing Hong-mei,Wang Shu-ye,Cen Xi-nan,Liu Hui,Liu Ai-chun,Li Zeng-jun,Luo Jian-min,He Jian-xia,Wang Jing-wen,O’Connor O. A.,Zhou Dao-bin

Funder

the National Natural Science Foundation of China

Beijing Municipal Natural Science Foundation

Chinese Academy of Medical Sciences Innovation Fund

National High Level Hospital Clinical Research Funding

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00277-024-05708-w.pdf

Reference24 articles.

1. Weisenburger DD, Savage KJ, Harris NL, Gascoyne RD, Jaffe ES, MacLennan KA et al (2011) Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood 117(12):3402–3408. https://doi.org/10.1182/blood-2010-09-310342

2. Chihara D, Fanale MA, Miranda RN, Noorani M, Westin JR, Nastoupil LJ et al (2017) The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma. Br J Haematol 176(5):750–758. https://doi.org/10.1111/bjh.14477

3. Rodríguez J, Conde E, Gutiérrez A, Arranz R, León A, Marín J et al (2007) The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish lymphoma and autologous transplantation group experience. Ann Oncol 18(4):652–657. https://doi.org/10.1093/annonc/mdl466

4. Reimer P, Rüdiger T, Geissinger E, Weissinger F, Nerl C, Schmitz N et al (2009) Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. J Clin Oncol 27(1):106–113. https://doi.org/10.1200/jco.2008.17.4870

5. d’Amore F, Relander T, Lauritzsen GF, Jantunen E, Hagberg H, Anderson H et al (2012) Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol 30(25):3093–3099. https://doi.org/10.1200/jco.2011.40.2719